What long‑acting opioid regimen should be administered at bedtime to provide continuous analgesia for wound pain throughout the night?

Bedtime Opioid Regimen for Wound Pain

For patients receiving immediate-release morphine every 4 hours during the day, give a double dose at bedtime to provide continuous analgesia through the night. This simple, evidence-based strategy effectively prevents nocturnal pain awakening without causing problematic adverse effects 1, 2.

Primary Recommendation: Double-Dose Strategy

If your patient is already on immediate-release morphine every 4 hours (e.g., 10 mg every 4 hours during the day), administer 20 mg at bedtime 1, 2. This approach:

• Provides approximately 8 hours of analgesia through the night
• Has been widely adopted in clinical practice and proven safe
• Requires no complex calculations or new medications
• Does not produce troublesome adverse effects despite the higher single dose 1, 2

Important caveat: While no formal controlled trials have validated this practice, it represents expert consensus from the European Association for Palliative Care and has demonstrated consistent clinical effectiveness 1, 2.

Alternative: Modified-Release Formulations

If the patient is not yet on regular opioids or you prefer a different approach, consider 12-hourly modified-release morphine given at bedtime 2. This provides:

• Sustained analgesia for 12 hours
• Simplified dosing (one bedtime dose covers the entire night)
• Equal efficacy to immediate-release formulations for maintenance therapy 1

Dosing guidance: Calculate the total daily morphine requirement from daytime use, divide by 2, and give one dose at bedtime. Keep immediate-release morphine available for breakthrough pain (dose = one-third of the 12-hour dose, equivalent to the 4-hourly dose) 1.

When Modified-Release Fails: 8-Hour Dosing

A small subset of patients do not achieve full 12-hour coverage with standard modified-release formulations 1. If pain consistently returns before morning:

• Switch to 8-hourly dosing of modified-release morphine
• This is occasionally necessary and clinically acceptable
• Patients on high doses may also prefer this to avoid taking excessive tablets at once 2, 1

Route Considerations

Oral route is optimal 1, 2. If the patient cannot take oral medications:

• Rectal morphine: Use the same dose as oral (1:1 bioavailability and duration) 1
• Subcutaneous morphine: Use 1/2 to 1/3 of the oral dose (oral:subcutaneous ratio is approximately 2-3:1) 2
• Never crush modified-release tablets for rectal or other alternative routes 1

Critical Pitfalls to Avoid

1. Do not increase dosing frequency unnecessarily - Increasing the dose maintains adequate analgesia without the inconvenience and compliance issues of more frequent administration 1

2. Ensure breakthrough medication is available - Even with optimal nighttime coverage, patients need access to immediate-release morphine for unexpected pain episodes 2

3. Avoid intramuscular administration - Subcutaneous is simpler, less painful, and equally effective for chronic pain 1, 2

4. Monitor for constipation - This is the main persistent adverse effect requiring prophylactic laxatives in nearly all patients 2

Practical Implementation

Step-by-step approach:

1. Calculate current 4-hourly immediate-release dose
2. Double this dose for bedtime administration
3. Prescribe immediate-release morphine for breakthrough pain (same as 4-hourly dose)
4. Reassess pain control the following morning
5. If patient awakens with pain, increase the regular daytime doses first, then recalculate the bedtime double dose 1

Quality of life consideration: Uninterrupted sleep significantly improves treatment outcomes and patient compliance 3, 4. The double-dose bedtime strategy directly addresses this by preventing nocturnal pain awakening, allowing patients to focus on recovery rather than pain management during rest hours.